97 results
Page 5 of 5
6-K
EX-99.1
2cyr173dn36oamkj
25 Jun 18
Aurinia Initiates Clinical Trials Broadening the Development of Voclosporin
11:32am
6-K
EX-99.1
a1fl3bgp4lfab0xf0nu0
22 Jun 18
Aurinia Announces Results of Annual General Meeting
4:30pm
6-K
EX-99.2
jn0kkno6bs5l n4i5c
10 May 18
Current report (foreign)
4:06pm
6-K
EX-99.1
yw3iutsvh of
10 May 18
Aurinia Reports First Quarter Financial Results and Operational Highlights
4:03pm
6-K
EX-99.1
e31v0x 33xe2m
20 Oct 17
Aurinia to Expand Renal Franchise with Novel Indications and Launches Development Program for Treatment of Dry Eye Syndrome
12:00am
6-K
EX-99.1
lm9sz3
20 Apr 17
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
jkf1 x9iwjw
21 Nov 16
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
cuug1q
24 Oct 16
Aurinia Announces Acceptance of Late-Breaking Voclosporin Abstracts for Oral Presentation at Upcoming Medical Meetings
12:00am
6-K
EX-99.1
pc72xvypem
6 Oct 16
Aurinia Releases Open-Label AURION Data Demonstrating Increased Remission Rates over Time for Voclosporin in the Treatment of Lupus Nephritis
12:00am
6-K
EX-99.1
3wxs3 kw1z2rbe1
4 Feb 15
Aurinia Pharmaceuticals Inc. 6-K
12:00am
40FR12B/A
EX-99.25
t0uixywth4t06s r4vx2
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.24
0cj56lj16
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.15
jp7z9jyughu4lm
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.26
toj5ynm 0x
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.16
l9nr9y8
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.27
7ygzid05
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B
EX-99.1
84hnfemzai
16 Apr 14
Initial registration of securities (Canada)
12:00am